EUVIMEDEUVIMED entdecken
Crossref

Is histopathological synovitis score a predictor of postoperative requirement for additional or alternative drug treatment in the patients with rheumatoid arthritis?

Kensuke Koyama, Masanori Wako, Tetsuro Ohba, Daiki Nakagomi, Ryousuke Koizumi, Hirotaka Haro

Modern Rheumatology · 2023

DOI: 10.1093/mr/roac108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2023. Verfasst von Kensuke Koyama und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synovitis, Arthroplasty, Replacement, Knee. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Histopathological synovitis scoring is useful for assessing activity in patients with rheumatoid arthritis (RA) at sampling, but it is unclear whether it can be a predictor of future drug treatment. The purpose of this study was to examine whether histopathological synovitis score is a predictor of postoperative requirement for additional or alternative drug treatment after total knee arthroplasty (TKA).

Methods

Thirty patients with RA in whom synovial samples were obtained during TKA were included. Patients were divided into the drug treatment enhanced group (EG), which included patients who needed additional or alternative drug treatment within 1 year after TKA, and the drug treatment maintenance group (MG). The Rooney synovitis score (RSS) was compared between groups. Logistic regression analysis was performed to clarify prognostic factors for postoperative drug treatment change.

Results

The total RSS was significantly higher in the EG than in the MG (29.3 vs 15.1; P < .001). Multivariate analysis showed that total RSS and swollen joint counts were independent variable associated with postoperative requirement for additional or alternative drug treatment (P < .05).

Conclusions

Histopathological synovitis scoring may predict requirement for additional or alternative drug treatment in patients with RA after TKA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSynovitisArthroplasty, Replacement, KneeHumans

Stichwörter der Autor:innen

DAS28-CRPRooney synovitis scorehistopathological synovitispredictorrheumatoid arthritis

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Centre for Clinical Immunology and Rheumatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Department of Rheumatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.

Zitieren

APA

Koyama, K., Wako, M., Ohba, T., Nakagomi, D., Koizumi, R., & Haro, H. (2023). Is histopathological synovitis score a predictor of postoperative requirement for additional or alternative drug treatment in the patients with rheumatoid arthritis?. Modern Rheumatology. https://doi.org/10.1093/mr/roac108

Vancouver

Koyama K, Wako M, Ohba T, Nakagomi D, Koizumi R, Haro H. Is histopathological synovitis score a predictor of postoperative requirement for additional or alternative drug treatment in the patients with rheumatoid arthritis?. Modern Rheumatology. 2023. doi:10.1093/mr/roac108

BibTeX
@article{Koyama2023,
  author = {Koyama, Kensuke and Wako, Masanori and Ohba, Tetsuro and Nakagomi, Daiki and Koizumi, Ryousuke and Haro, Hirotaka},
  title = {Is histopathological synovitis score a predictor of postoperative requirement for additional or alternative drug treatment in the patients with rheumatoid arthritis?},
  journal = {Modern Rheumatology},
  year = {2023},
  doi = {10.1093/mr/roac108}
}
Kostenlos starten →